Section Menu

    COVID-19 & Influenza Therapies

    Refer Patients to Owensboro Health Regional Hospital

    The following referral forms are to be used by medical professionals. Patients who are interested in receiving any of the following therapies should ask their current provider for a referral.

    COVID-19 Therapies

    Monoclonal Antibody Treatment 

    There are currently no Monoclonal Antibody Treatment therapies approved by the FDA to treat the current variant of COVID-19. As therapies become approved, this page will be updated with pertinent information.

    Questions?

    Please call the OHRH Inpatient Pharmacy at 270-417-6700.

    Paxlovid (Oral COVID-19 Therapy)

    Nirmatrelivr/ritonavir (Paxlovid) has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is not authorized for use as a pre-exposure or post-exposure prophylaxis for prevention for COVID-19.

    Paxlovid should be initiated as soon as possible after a diagnosis of COVID-19 and within 5 days of symptom onset.  Therapy is twice-daily dosing for 5 days. Renal adjustments are necessary depending on the level of renal function.

    INVENTORY STATUS: Limited Supply Available 

    To ensure you have the most up-to-date information and Paxlovid Order Form, please visit the link below each day you plan to order Paxlovid.

    Download the Paxlovid Referral Form

    Questions?

    Please call the OHRH Outpatient Pharmacy at 270-417-6701.

    Evusheld Monoclonal Antibody Treatment

    The Evusheld Monoclonal Antibody Treatment therapy is no longer approved by the FDA to treat the current variant of COVID-19. As therapies become approved, this page will be updated with pertinent information.

    Questions?

    Please call the OHRH Inpatient Pharmacy at 270-417-6700.
     

    Influenza Therapies

    Tamilflu

    • Tamiflu is available in limited supplies (The most cost-efficient therapy on outpatient basis)
      • Can be ordered by any provider
      • Can be ordered per protocol within 48 hours of symptom onset
         
    • Patients admitted to OHRH, Tamiflu is reserved for the following:
      • Children less than 5 years old
      • Pregnant patients
      • Breastfeeding mothers

    Questions?

    Please contact the OHRH Outpatient Pharmacy at 270-417-6700.

    Xofluza

    • Single-dose therapy
    • This therapy is available through OHRH Outpatient Pharmacy 
    • Available for inpatients at OHRH, excluding where contraindicated
      • Children less than 5 years old
      • Pregnant patients
      • Breastfeeding mothers

    Questions?

    Please contact the OHRH Outpatient Pharmacy at 270-417-6700.